Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Apr 23, 2024 12:18pm
102 Views
Post# 36003440

RE:RE:RE:RE:short interest

RE:RE:RE:RE:short interest
It is true that oncy can call the warrants anytime in the 60 month time frame under the following conditions as noted by the following from the warrant agreement....

The expiry of the Warrants may be accelerated by the Corporation at any time prior to the Expiry Date if the volume
weighted average price (if applicable, as converted to U.S. dollars at the Bank of Canada posted rate for the
respective trading day) of the issued and outstanding Common Shares on the TSX or such other principal stock
exchange on which the Common Shares are then listed and posted for trading is greater than US$6.50 for any 20

consecutive trading days, at which time the Corporation may, within 10 business days, accelerate the Expiry Date by
issuing a press release announcing the reduced warrant term whereupon the Warrants will expire on or after the 75th
calendar day after the date of such press release.
<< Previous
Bullboard Posts
Next >>